Molecular Classification of Thyroid Nodules with Indeterminate Cytology: Development and Validation of a Highly Sensitive and Specific New miRNA-Based Classifier Test Using Fine-Needle Aspiration Smear Slides
Молекулярная классификация узловых образований щитовидной железы с неопределённой цитологической картиной: разработка и валидация нового высокочувствительного и высокоспецифичного теста-классификатора на основе микроРНК с использованием мазков, полученных при тонкоигольной аспирационной биопсии
2018-10-15
SCID: 54.1/tjrrfzkg
Discuss with AI
fine-needle aspirationindeterminate cytologymicroRNA classifierprecision endocrinologythyroid nodules
Figures from the paper
Abstract (AI)
Background: Thyroid nodules can be identified in up to 68% of the population. Fine-needle aspiration (FNA) cytopathology classifies 20%–30% of nodules as indeterminate, and these are often referred for surgery due to the risk of malignancy. However, histological postsurgical reports indicate that up to 84% of cases are benign, highlighting a high rate of unnecessary surgeries. We sought to develop and validate a microRNA (miRNA)-based thyroid molecular classifier for precision endocrinology (mir-THYpe) with both high sensitivity and high specificity, to be performed on the FNA cytology smear slide with no additional FNA. Methods: The expression of 96 miRNA candidates from 39 benign/39 malignant thyroid samples, (indeterminate on FNA) was analyzed to develop and train the mir-THYpe algorithm. For validation, an independent set of 58 benign/37 malignant FNA smear slides (also classified as indeterminate) was used. Results: In the training set, with a 10-fold cross-validation using only 11 miRNAs, the mir-THYpe test reached 89.7% sensitivity, 92.3% specificity, 90.0% negative predictive value and 92.1% positive predictive value. In the FNA smear slide validation set, the mir-THYpe test reached 94.6% sensitivity, 81.0% specificity, 95.9% negative predictive value, and 76.1% positive predictive value. Bayes' theorem shows that the mir-THYpe test performs satisfactorily in a wide range of cancer prevalences. Conclusions: The presented data and comparison with other commercially available tests suggest that the mir-THYpe test can be considered for use in clinical practice to support a more informed clinical decision for patients with indeterminate thyroid nodules and potentially reduce the rates of unnecessary thyroid surgeries.
Key Findings
1
Bayesian analysis indicated satisfactory mir-THYpe performance across a wide range of thyroid cancer prevalences.
2
In 10-fold cross-validation, mir-THYpe achieved 89.7% sensitivity, 92.3% specificity, 90.0% negative predictive value, and 92.1% positive predictive value.
3
On an independent validation set of 95 indeterminate FNA smear slides, the test achieved 94.6% sensitivity, 81.0% specificity, 95.9% negative predictive value, and 76.1% positive predictive value.
4
The findings suggest mir-THYpe could support clinical decisions and potentially reduce unnecessary surgery for patients with indeterminate thyroid nodules.
5
The study developed mir-THYpe, an 11-miRNA classifier designed to assess indeterminate thyroid nodules using existing FNA smear slides without additional sampling.
Research Object
Thyroid nodules with indeterminate fine-needle aspiration cytology, represented by FNA smear slides and classified as benign or malignant
Research Subject
miRNA-expression patterns and the diagnostic performance of a molecular classifier for distinguishing benign from malignant thyroid nodules, including sensitivity, specificity, and predictive values
Publication Details
Publication Date
2018-10-15
Journal
Publisher
ISSN
Cited by
54
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer2015
Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules2018